Physician profile
Andrew Nathanson
NPI 1508433020
$2,112.20
in general payments reported to CMS, 2019-2025
16 companies · $843 in 2025
The $843 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $221 · 2024: $929 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $492.08 | 2023-2025 | Evenity, Repatha, Otezla |
| Cequr Corporation | $367.69 | 2024-2025 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals LP | $243.68 | 2024-2025 | Airsupra |
| Novo Nordisk INC | $232.08 | 2024-2025 | Wegovy |
| Ascendis Pharma Endocrinology INC | $231.84 | 2023-2025 | Yorvipath |
| Abbvie INC. | $141.32 | 2024-2025 | |
| Corcept Therapeutics | $113.55 | 2025 | Korlym |
| Lilly USA, LLC | $90.10 | 2024 | Mounjaro |
| Janssen Biotech, INC. | $80.42 | 2022-2024 | Darzalex, Imbruvica |
| Regeneron Healthcare Solutions, INC. | $22.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.69 | 2022 | |
| Exact Sciences Corporation | $16.68 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $16.48 | 2024 | |
| Amryt Pharma Holdings LTD | $15.07 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.16 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $13.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nathanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.